Teva Pharmaceutical Industries Bdr (T1EV34) Stock Price & News

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia

About Teva Pharmaceutical Industries Bdr

CEORichard Francis

Employees32 мян

Founded1944 оны 2-р сарын 13

Headquarters-

SectorPharmaceutical industry

Websiteteva.co.il

All values in USD	2025 оны 6-р сар	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар
Revenue	4.18 тэрбум	4.48 тэрбум	4.71 тэрбум	3.98 тэрбум
Cost of goods sold	2.07 тэрбум	2.18 тэрбум	2.06 тэрбум	2.01 тэрбум
Cost of revenue	2.07 тэрбум	2.18 тэрбум	2.06 тэрбум	2.01 тэрбум
Research and development expenses	244.00 сая	256.00 сая	267.00 сая	222.00 сая
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	959.00 сая	973.00 сая	1.12 тэрбум	1.00 тэрбум
Operating expense	1.21 тэрбум	1.24 тэрбум	1.37 тэрбум	1.21 тэрбум
Total operating expenses	3.28 тэрбум	3.41 тэрбум	3.43 тэрбум	3.22 тэрбум
Operating income	894.00 сая	1.07 тэрбум	1.28 тэрбум	763.00 сая
Other non operating income	-90.00 сая	-27.00 сая	-	-13.00 сая
EBT including unusual items	204.00 сая	648.00 сая	90.00 сая	436.00 сая
EBT excluding unusual items	643.00 сая	832.00 сая	1.08 тэрбум	547.00 сая
Income tax expense	-78.00 сая	214.00 сая	-390.00 сая	67.00 сая
Effective tax rate	-38.24%	33.02%	-433.33%	15.37%
Other operating expenses	5.00 сая	9.00 сая	-17.00 сая	-14.00 сая
Net income	282.00 сая	433.00 сая	480.00 сая	369.00 сая
Net profit margin	6.75%	9.67%	10.19%	9.27%
Earnings per share	0.66	0.78	0.96	0.53
Interest and investment income	-	-	92.00 сая	-
Interest expense	-220.00 сая	-205.00 сая	-280.00 сая	-191.00 сая
Net interest expenses	-220.00 сая	-205.00 сая	-188.00 сая	-191.00 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	1.14 тэрбум	1.32 тэрбум	1.54 тэрбум	1.00 тэрбум
Gain or loss from assets sale	-2.00 сая	-	-	-8.00 сая

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research